Remove Distribution Remove Pharmaceutical manufacturing Remove Prescription
article thumbnail

Leading pharmaceutical wholesalers

Pharmaceutical Technology

Pharmaceutical wholesalers act as intermediaries between pharmaceutical manufacturers and retailers and facilitate the delivery of the right medicines in a timely, efficient, and secure manner. Wholesale distributors are responsible for guaranteeing product quality and preventing the influx of counterfeited drugs.

Leads 52
article thumbnail

Affordability Programs Need a Technology Makeover

PM360

The cost of filling a prescription can keep 21% of patients from getting an Rx, and one in ten patients will modify their treatment plan because of cost, according to recent polling data from KFF. It all starts with reaching HCPs and pharmacists across POC platforms with program information at the points of prescription and dispensing.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Solving pharma’s process development challenges one API at a time

Pharmaceutical Technology

If clinical trials prove successful, that same process should then be scaled to commercial manufacturing. A large part of process development involves the selection of pharmaceutical manufacturing equipment for blending, extrusion, drying, milling, and micronization.

article thumbnail

Should we be worried about pharma’s supply chain?

World of DTC Marketing

The US Food and Drug Administration (FDA) believes the adulteration of heparin was an economically motivated act—a clear breach of the US pharmaceutical supply chain. The answer lies in both an outdated way we develop prescription drugs and the continued quest for the next big blockbuster. In other words, money over safety.

article thumbnail

CMS enters drug price negotiation arena in sea change for industry

Clarivate

Although the reported negotiated prices may ignore the real-world role of contracting by manufacturers and private payers over formulary placement, the reported prices nonetheless are likely to have downstream impacts on how private payers reimburse these therapies and their competitors. These ten drugs cost Medicare Part D nearly $46.8